Aethlon Medical (AEMD) News Today $0.66 -0.05 (-7.10%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.comJanuary 11, 2025 | americanbankingnews.comAethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird FluDecember 20, 2024 | prnewswire.comAethlon’s Future at Risk: Financial Struggles, Stockholder Dilution, and Market Challenges LoomNovember 15, 2024 | markets.businessinsider.comMaxim Group Sticks to Their Hold Rating for Aethlon Medical (AEMD)November 15, 2024 | markets.businessinsider.comAethlon Medical, Inc. (NASDAQ:AEMD) Q2 2025 Earnings Call TranscriptNovember 15, 2024 | msn.comAethlon Medical Advances Oncology Trials and Global ExpansionNovember 15, 2024 | markets.businessinsider.comAEMD: Oncology Trial Moves Forward as Patient Enrollments Begin, Positive on Cost Containment MeasuresNovember 15, 2024 | msn.comAethlon Medical Reports Progress in Oncology TrialsNovember 14, 2024 | markets.businessinsider.comAethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comAethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate UpdateNovember 13, 2024 | prnewswire.comAethlon Medical enrolls first patient in Hemopurifier cancer trial in AustraliaNovember 12, 2024 | markets.businessinsider.comAn Overview of Aethlon Medical's EarningsNovember 12, 2024 | benzinga.comAethlon Medical, Inc.: Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier Cancer Trial in AustraliaNovember 11, 2024 | finanznachrichten.deAethlon Medical enrols first patient in trial of Hemopurifier device for cancerNovember 11, 2024 | msn.comAethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in AustraliaNovember 11, 2024 | prnewswire.comAethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024November 6, 2024 | prnewswire.comAethlon Medical Inc (AEMD) Q1 2025 Earnings Call Highlights: Strategic Cost Management and ...October 10, 2024 | finance.yahoo.comAethlon Medical to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 8, 2024 | prnewswire.comAethlon Medical (NASDAQ:AEMD) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comAEMD: Positive Takeaways from Life Science Investor Forum PresentationSeptember 24, 2024 | msn.comEcon Corp Services DBA Investorideas.com: Immunotherapy Clinical Trials - A New Approach to Treating CancerSeptember 21, 2024 | finanznachrichten.deAethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in IndiaSeptember 19, 2024 | prnewswire.comAethlon begins patient enrollment in Hemopurifier cancer trialSeptember 18, 2024 | uk.investing.comAethlon Medical to Present at Virtual Investor Conferences in SeptemberSeptember 17, 2024 | prnewswire.comAethlon Medical (NASDAQ:AEMD) Stock Quotes, Forecast and News SummarySeptember 17, 2024 | benzinga.comAethlon Gains on Product NewsSeptember 16, 2024 | baystreet.caAethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer TrialSeptember 16, 2024 | prnewswire.comAethlon Medical to Present at the Life Sciences Investor Forum September 19thSeptember 13, 2024 | globenewswire.comAethlon Medical's Hemopurifier shows promise in kidney studyAugust 29, 2024 | investing.comWORK Medical Technology Group LTD (WOK)August 28, 2024 | finance.yahoo.comAethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor KidneysAugust 27, 2024 | prnewswire.comAethlon Medical, Inc. (AEMD) Q1 2025 Earnings Call TranscriptAugust 16, 2024 | seekingalpha.comAEMD: Oncology Trial Advancing; Approval from 2nd SiteAugust 15, 2024 | msn.comAEMD Stock Earnings: Aethlon Medical Misses EPS for Q1 2025August 15, 2024 | markets.businessinsider.comAethlon Medical, Inc. (NASDAQ:AEMD) Q1 2025 Earnings Call TranscriptAugust 15, 2024 | msn.comAethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate UpdateAugust 14, 2024 | prnewswire.comAethlon Medical, Inc.: Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier Cancer TrialAugust 13, 2024 | finanznachrichten.deAethlon Medical receives ethics committee approval for trial of cancer treatmentAugust 13, 2024 | finance.yahoo.comAethlon Enjoys Slight Gains on Ethics ApprovalAugust 12, 2024 | msn.comAethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer TrialAugust 12, 2024 | prnewswire.comAethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024August 6, 2024 | prnewswire.comAEMD Stock Earnings: Aethlon Medical Beats EPS for Q4 2024June 27, 2024 | investorplace.comAethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate UpdateJune 27, 2024 | prnewswire.comAethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024June 21, 2024 | prnewswire.comAethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer TrialJune 18, 2024 | prnewswire.comWhy Is Aethlon Medical (AEMD) Stock Up 82% Today?June 6, 2024 | investorplace.comAethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment StudiesJune 3, 2024 | prnewswire.comAethlon Medical Announces Pricing of $4.7 Million Public OfferingMay 15, 2024 | prnewswire.comAethlon Medical Stock Surges In Pre-market On Positive Hemopurifier Trial ResultsMay 10, 2024 | markets.businessinsider.comAethlon Medical Shares Double After Positive Results from Early Trial of HemopurifierMay 10, 2024 | marketwatch.com Get Aethlon Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter. Email Address AEMD Media Mentions By Week AEMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AEMD News Sentiment▼-0.500.41▲Average Medical News Sentiment AEMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AEMD Articles This Week▼11▲AEMD Articles Average Week Get Aethlon Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NMTC News NXL News COCH News SURG News POCI News IRIX News DRIO News XAIR News CODX News BSGM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AEMD) was last updated on 1/19/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aethlon Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
